Filter
360
Text search:
JAMA
Network
Featured
Recommendations
40
New Publications
51
Language
Document type
No document type
145
Guidelines
100
Studies & Reports
77
Manuals
16
Training Material
7
Strategic & Response Plan
6
Situation Updates
4
Fact sheets
4
Resource Platforms
1
Countries / Regions
India
15
Brazil
13
Russia
12
Global
12
Africa
11
Latin America and the Carribbean
10
Western and Central Europe
10
Mozambique
7
Eastern Europe
7
Germany
6
Syria
5
Ukraine
5
East and Southern Africa
5
South Africa
4
Angola
4
Eastern Europe and Central Asia
4
Liberia
3
Nigeria
3
Uganda
3
Rwanda
3
West and Central Africa
3
Middle East and North Africa
3
Guinea
2
Sierra Leone
2
Guinea-Bissau
2
Philippines
2
Kenya
2
Tanzania
2
Thailand
2
South–East Asia Region
2
Portugal
2
Burkina Faso
1
Congo, Democratic Republic of
1
USA
1
Ethiopia
1
Ghana
1
Zimbabwe
1
South Sudan
1
Iraq
1
Afghanistan
1
Turkey
1
Cambodia
1
Indonesia
1
Bangladesh
1
Malawi
1
Eswatini/ Swaziland
1
Colombia
1
Mexico
1
Yemen
1
Canada
1
Tajikistan
1
Kyrgyzstan
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
85
Public Health
28
Clinical Guidelines
26
Women & Child Health
19
Pharmacy & Technologies
7
Key Resources
4
Capacity Building
1
Toolboxes
COVID-19
102
Mental Health
52
HIV
31
NCDs
23
TB
15
AMR
14
Planetary Health
11
Global Health Education
7
Caregiver
7
Ebola
6
Rapid Response
6
Refugee
6
Conflict
4
Health Financing Toolbox
4
Disability
3
Polio
3
Natural Hazards
2
Pharmacy
2
Cholera
1
Zika
1
Specific Hazards
1
NTDs
1
In this quality improvement study, data from the Creditor Reporting System were used to estimate flows of total DAAH and per-adolescent DAAH and to assess its distribution by donors, regions, and countries and the leading causes of burden of disease (ie,
disability-adjusted life-years) in 132 devel
...
In 2015, member states of the United Nations adopted the ambitious Sustainable Development Goals (SDGs), which included 17 global goals that targeted economic and social development.1 Goal 3, “to ensure healthy lives and promote well-being for all at all ages,” targets specifically marked progre
...
Check back here for updates on COVID-19 diagnosis and treatment
The aim of this paper is to map and critically analyse evidence of good practice in prevention and response to gender-based violence (GBV) in humanitarian contexts which can support humanitarian practitioners and policy makers to improve the quality of GBV programming in the field. The paper is stru
...
Health Evidence Network Synthesis Report, No. 47
The increasing number of refugees, asylum seekers and irregular migrants poses a challenge for mental health services in Europe. This review found that these groups are exposed to risk factors for me
...
Policy brief, 24 July 2020
The COVID-19 pandemic has affected older people disproportionately, especially those living in long-term care facilities. In many countries, evidence shows that more than 40% of COVID-19 related deaths have been linked to long-term care facilities, with figures being as h
...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t
...
Update, 23 de junio de 2022
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I
...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE
...
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Health systems in Latin America face many challenges in controlling the increasing burden of diabetes. Digital health interventions are a promise for the provision of care, especially in developing countries where mobile technology has a high penetration. This study evaluated the effectiveness of th
...
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and
...
This document updates the 2014 Core Elements for Hospital Antibiotic Stewardship Programs and incorporates new evidence and lessons learned from experience with the Core Elements. The Core Elements are applicable in all hospitals, regardless of size. There are suggestions specific to small and criti
...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid
...
The COVID-19 HEalth caRe wOrkErs Study (HEROES): Regional Report from the Americas is a multicenter prospective cohort study to assess the impact of the COVID-19 pandemic on the mental health of health care workers in 26 countries on four continents and how it is affected by several factors at diffe
...
Eurosurveillance
Impact Factor 5.7
June 2015
www.eurosurveillance.org
Featuring a series of articles on HIV and STI epidemiology, prevention and control among MSM in Europe
interim guidance, 19 July 2021 (arabic version)
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
